Annual Cash & Cash Equivalents
$2.91 M
+$2.78 M+2173.61%
December 31, 2023
Summary
- As of February 7, 2025, CTCX annual cash & cash equivalents is $2.91 million, with the most recent change of +$2.78 million (+2173.61%) on December 31, 2023.
- During the last 3 years, CTCX annual cash & cash equivalents has risen by +$2.90 million (+23387.90%).
- CTCX annual cash & cash equivalents is now at all-time high.
Performance
CTCX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.14 M
-$1.06 M-48.26%
September 30, 2024
Summary
- As of February 7, 2025, CTCX quarterly cash and cash equivalents is $1.14 million, with the most recent change of -$1.06 million (-48.26%) on September 30, 2024.
- Over the past year, CTCX quarterly cash and cash equivalents has dropped by -$6.83 million (-85.73%).
- CTCX quarterly cash and cash equivalents is now -85.73% below its all-time high of $7.97 million, reached on September 30, 2023.
Performance
CTCX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CTCX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2173.6% | -85.7% |
| 3 y3 years | +10000.0% | +787.8% |
| 5 y5 years | +10000.0% | +787.8% |
CTCX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -85.7% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -85.7% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -85.7% | >+9999.0% |
Carmell Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.14 M(-48.3%) |
| Jun 2024 | - | $2.20 M(+146.4%) |
| Mar 2024 | - | $892.20 K(-69.4%) |
| Dec 2023 | $2.91 M | $2.91 M(-63.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $7.97 M(>+9900.0%) |
| Jun 2023 | - | $10.20 K(-92.0%) |
| Dec 2022 | $128.10 K(+933.1%) | $128.10 K |
| Dec 2021 | $12.40 K | - |
FAQ
- What is Carmell Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Carmell Therapeutics?
- What is Carmell Therapeutics annual cash & cash equivalents year-on-year change?
- What is Carmell Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Carmell Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CTCX is $2.91 M
What is the all time high annual cash & cash equivalents for Carmell Therapeutics?
Carmell Therapeutics all-time high annual cash & cash equivalents is $2.91 M
What is Carmell Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CTCX annual cash & cash equivalents has changed by +$2.78 M (+2173.61%)
What is Carmell Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CTCX is $1.14 M
What is the all time high quarterly cash and cash equivalents for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly cash and cash equivalents is $7.97 M
What is Carmell Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CTCX quarterly cash and cash equivalents has changed by -$6.83 M (-85.73%)